1AI
Click for more information
0.00% 1.0¢ algorae pharmaceuticals limited

Ann: Approval granted for group 3 in Parkinsons trial

  1. ASX News
    lightbulb Created with Sketch. 851
    clock Created with Sketch.
    08/02/17
    10:36
    Post #: 22448108
    Likes Created with Sketch. 2  Upvote
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

LRV Larvotto identifies new exploration target at NSW's Hillgrove, boosting shares by nearly 20%
right-arrow Created with Sketch.
BIO Biome posts record sales revenue of $13M in FY24 – up 80% vs pcp and higher than forecast
right-arrow Created with Sketch.
ITM iTech lifts MRE at Eyre Peninsula Graphite Project by 300%
right-arrow Created with Sketch.
NEWS Has uranium run out of steam? An update on nuclear markets & developments ahead in FY25
right-arrow Created with Sketch.
AHK Ark Mines defines significant exploration target at Sandy Mitchell rare earths project
right-arrow Created with Sketch.
EX1 Tryptamine Therapeutics completes maiden dosing of IV psilocin – a global first
right-arrow Created with Sketch.
watchlist Created with Sketch. Add 1AI (ASX) to my watchlist
(20min delay)
Last
1.0¢ 		Change
0.000(0.00%) 		Mkt cap ! $16.87M
Open High Low Value Volume
1.0¢ 1.0¢ 1.0¢ $2K 200K

Buyers (Bids)

No. Vol. Price($)
5 4435009 0.9¢
 

Sellers (Offers)

Price($) Vol. No.
1.0¢ 4596 1
View Market Depth
Last trade - 10.03am 03/07/2024 (20 minute delay) ?
1AI (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.